| __timestamp | Dr. Reddy's Laboratories Limited | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 38783000000 | 49315000 |
| Thursday, January 1, 2015 | 42585000000 | 75043000 |
| Friday, January 1, 2016 | 45702000000 | 83749000 |
| Sunday, January 1, 2017 | 46372000000 | 122682000 |
| Monday, January 1, 2018 | 46910000000 | 207761000 |
| Tuesday, January 1, 2019 | 48890000000 | 284812000 |
| Wednesday, January 1, 2020 | 50129000000 | 317875000 |
| Friday, January 1, 2021 | 54559000000 | 282660000 |
| Saturday, January 1, 2022 | 62081000000 | 451421000 |
| Sunday, January 1, 2023 | 105931000000 | 481871000 |
| Monday, January 1, 2024 | 77201000000 |
Cracking the code
In the world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Dr. Reddy's Laboratories Limited and Sarepta Therapeutics, Inc. offer a fascinating study in contrasts. From 2014 to 2023, Dr. Reddy's Laboratories saw a steady increase in SG&A expenses, peaking in 2023 with a staggering 173% rise from 2014. In contrast, Sarepta Therapeutics, Inc. experienced a more modest growth, with expenses increasing by approximately 878% over the same period. This disparity highlights the different scales and strategies of these companies. While Dr. Reddy's Laboratories operates on a global scale, Sarepta's focus on niche markets may explain its more conservative expense growth. Notably, data for 2024 is incomplete, leaving room for speculation on future trends. Understanding these dynamics is key for investors and industry analysts alike.
Cost Management Insights: SG&A Expenses for AbbVie Inc. and Sarepta Therapeutics, Inc.
Selling, General, and Administrative Costs: Sanofi vs Dr. Reddy's Laboratories Limited
Cost Management Insights: SG&A Expenses for Gilead Sciences, Inc. and Sarepta Therapeutics, Inc.
Neurocrine Biosciences, Inc. vs Sarepta Therapeutics, Inc.: SG&A Expense Trends
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Dr. Reddy's Laboratories Limited vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Dr. Reddy's Laboratories Limited and Celldex Therapeutics, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Dr. Reddy's Laboratories Limited or Evotec SE
SG&A Efficiency Analysis: Comparing Sarepta Therapeutics, Inc. and Exelixis, Inc.
Operational Costs Compared: SG&A Analysis of Sarepta Therapeutics, Inc. and Alkermes plc
Cost Management Insights: SG&A Expenses for Sarepta Therapeutics, Inc. and Ionis Pharmaceuticals, Inc.
Comparing SG&A Expenses: Sarepta Therapeutics, Inc. vs Wave Life Sciences Ltd. Trends and Insights